Lab Automation Market Detail Analysis of Current and Future Projection 2023 to 2033

The Lab Automation Market Demand is estimated to grow at a CAGR of 10.1% during the forecast period. The market is expected to rise from 2.1 billion US dollars in 2023 to 5.5 billion US dollars by 2033.

Research and Innovations Aid Market Growth

The market is held together by consistent demand for pharmaceutical research. Furthermore, automation is spreading throughout the pharmaceutical and healthcare industries. Both of these are beneficial to the market, particularly in developing countries. Key players are also interested in producing industry-specific products that satisfy the needs of certain Lab Automation users.

Fertile Ground for Market Growth

To keep up with the rapid rate of product acceptance, key enterprises must invest more in product development. This year is expected to be advantageous for global market expansion due to factors such as improved diagnostic rates. Current trends indicate that major competitors are pooling their resources to bolster their market positions through mergers and acquisitions.

Technological Innovations Emerge as an Integral Part of Market Growth

Long-term Lab Automation market prospects are expected to be driven by end-user demand for high-end, advanced Lab Automation technologies. Lab robotics technology advancements, which are still in their early phases, are projected to boost market expansion. To attract pharmaceutical and healthcare organisations of all sizes, Lab Automation systems must be incredibly frictionless and efficient.

Key Market Players:

  • Abbott Laboratories
  • Agilent Technologies
  • Perkin Elmer, Inc
  • Thermo Fisher Scientific, Inc
  • Siemens Healthcare
  • Danaher Corporation
  • Becton
  • Dickinson and Company
  • Transcriptic, Inc.

Browse More Details@ https://www.futuremarketinsights.com/reports/lab-automation-market

Key Segments

By Component Type:

  • Devices
    • Biochemistry Devices
    • Molecular Devices
    • Hematology Devices
    • Immunology Devices
    • Microbiology Devices
    • Others
  • Software
    • Scheduling Software
    • Momentum Integration Software

By Application:

  • Life Sciences Research and Development
  • Drug Discovery
  • Diagnostics

By End User:

  • Pharmaceutical Companies
  • Hospitals and Diagnostic Centers
  • Educational Institutions
  • Contract Research Organizations (CROs)
  • Research Institutes

Comments

Post a Comment

Popular posts from this blog

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

A Safer Tomorrow | Emerging Trends in Hospital-Acquired Infection Control Market

Image
According to Future Market Insights' recently released Hospital-acquired Infection Control Market analysis report, global Hospital-acquired Infection Control sales in 2023 are expected to be US$ 6.5 billion. The market is expected to increase at a CAGR of 7% between 2023 and 2033, reaching $12.7 billion by 2033. Hospitals and intensive care units are predicted to create significant income in the market, with a CAGR of 7.6%. The occurrence of hospital-acquired infections, increasing proportion of surgical procedures, growing geriatric population and increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the Hospital-acquired infection control market. The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, is predicted to increase demand for hospital-acquired infection management. The percentage of treatm
Read more

Transforming Trauma | Emerging Therapies and Interventions in Post-Traumatic Stress Disorder Treatment Market

Image
According to Future Market Insights, the Post-Traumatic Stress Disorder (PTSD) Treatment Market Sales would grow at a 5% CAGR between 2023 and 2033. By 2033, the global market for post-traumatic stress disorder (PTSD) therapy is expected to reach US$ 27.37 billion. The market's growth might be attributed to the increased prevalence of PTSD globally. According to the National Centre for PTSD, approximately 7-8% of the US population will develop PTSD at some point in their lives, with greater percentages among military veterans and persons who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been highlighted as a possible cause of PTSD, with healthcare workers, first responders, and people immediately impacted by the virus being especially vulnerable. In addition, there is a growing emphasis on using digital therapies and other non-pharmacological techniques to treat PTSD. For example, virtual reality exposure treatment (VRET) has shown potent
Read more